
NANO Nuclear Energy to Attend Upcoming Industry Focused Investor Conferences
New York, N.Y., Aug. 13, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) ('NANO Nuclear' or 'the Company'), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced its attendance at several upcoming industry focused investor events. 14 th Annual Needham Virtual Industrial Tech, Robotics, & Clean Tech Conference on Monday, August 18, 2025, held virtually.
on Monday, August 18, 2025, held virtually. TD Securities Nuclear & Uranium Conference on Tuesday, September 2, 2025, in London, UK.
on Tuesday, September 2, 2025, in London, UK. Barclays' 39th Annual Energy-Power Conference on Tuesday September 2, 2025, in New York, NY.
To request an invitation or to schedule a one-on-one meeting with NANO Nuclear management at one of these conferences, please contact your respective investment bank representatives or NANO Nuclear directly at [email protected].
NANO Nuclear will not be making formal presentations at these conferences but plans to do so at other investor conferences to be held in the coming months.
About NANO Nuclear Energy, Inc.
NANO Nuclear Energy Inc. (NASDAQ: NNE) is an advanced technology-driven nuclear energy company seeking to become a commercially focused, diversified, and vertically integrated company across five business lines: (i) cutting edge portable and other microreactor technologies, (ii) nuclear fuel fabrication, (iii) nuclear fuel transportation, (iv) nuclear applications for space and (v) nuclear industry consulting services. NANO Nuclear believes it is the first portable nuclear microreactor company to be listed publicly in the U.S.
Led by a world-class nuclear engineering team, NANO Nuclear's reactor products in development include patented KRONOS MMR™ Energy System, a stationary high-temperature gas-cooled reactor that is in construction permit pre-application engagement U.S. Nuclear Regulatory Commission (NRC) in collaboration with University of Illinois Urbana-Champaign (U. of I.), 'ZEUS', a solid core battery reactor, and 'ODIN', a low-pressure coolant reactor, and the space focused, portable LOKI MMR™, each representing advanced developments in clean energy solutions that are portable, on-demand capable, advanced nuclear microreactors.
Advanced Fuel Transportation Inc. (AFT), a NANO Nuclear subsidiary, is led by former executives from the largest transportation company in the world aiming to build a North American transportation company that will provide commercial quantities of HALEU fuel to small modular reactors, microreactor companies, national laboratories, military, and DOE programs. Through NANO Nuclear, AFT is the exclusive licensee of a patented high-capacity HALEU fuel transportation basket developed by three major U.S. national nuclear laboratories and funded by the Department of Energy. Assuming development and commercialization, AFT is expected to form part of the only vertically integrated nuclear fuel business of its kind in North America.
HALEU Energy Fuel Inc. (HEF), a NANO Nuclear subsidiary, is focusing on the future development of a domestic source for a High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication pipeline for NANO Nuclear's own microreactors as well as the broader advanced nuclear reactor industry.
NANO Nuclear Space Inc. (NNS), a NANO Nuclear subsidiary, is exploring the potential commercial applications of NANO Nuclear's developing micronuclear reactor technology in space. NNS is focusing on applications such as the LOKI MMR™ system and other power systems for extraterrestrial projects and human sustaining environments, and potentially propulsion technology for long haul space missions. NNS' initial focus will be on cis-lunar applications, referring to uses in the space region extending from Earth to the area surrounding the Moon's surface.
For more corporate information please visit: https://NanoNuclearEnergy.com/
For further NANO Nuclear information, please contact:
Email: [email protected]
Business Tel: (212) 634-9206
PLEASE FOLLOW OUR SOCIAL MEDIA PAGES HERE:
NANO Nuclear Energy LINKEDINNANO Nuclear Energy YOUTUBE
NANO Nuclear Energy X PLATFORM
Cautionary Note Regarding Forward Looking Statements
This news release and statements of NANO Nuclear's management in connection with this news release or at the investor conferences described herein contain or may contain 'forward-looking statements' within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as 'expects', 'anticipates', 'intends', 'plans', 'believes', 'potential', 'will', 'should', 'could', 'would' or 'may' and other words of similar meaning. All forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors, which may be beyond our control. For NANO Nuclear, particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following: (i) risks related to our U.S. Department of Energy ('DOE') or related state or non-U.S. nuclear licensing submissions, (ii) risks related the development of new or advanced technology and the acquisition of complimentary technology or businesses, including difficulties with design and testing, cost overruns, regulatory delays, integration issues and the development of competitive technology, (iii) our ability to obtain contracts and funding to be able to continue operations, (iv) risks related to uncertainty regarding our ability to technologically develop and commercially deploy a competitive advanced nuclear reactor or other technology in the timelines we anticipate, if ever, (v) risks related to the impact of U.S. and non-U.S. government regulation, policies and licensing requirements, including by the DOE and the U.S. Nuclear Regulatory Commission, including those associated with the recently enacted ADVANCE Act and the May 23, 2025 Executive Orders seeking to streamline nuclear regulation, and (vi) similar risks and uncertainties associated with the operating an early stage business a highly regulated and rapidly evolving industry. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement, and NANO Nuclear therefore encourages investors to review other factors that may affect future results in its filings with the SEC, which are available for review at www.sec.gov and at https://ir.nanonuclearenergy.com/financial-information/sec-filings. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Momentus Is Soaring on a NASA Contract Win. Should You Buy MNTS Stock Here?
Momentus (MNTS) shares nearly doubled on Wednesday morning after the commercial space firm said it has secured a terrestrial study contract from NASA. This study will explore 'options to fly advanced robotic systems in space aboard its orbital service vehicle flights,' the company revealed in its press release today. More News from Barchart Warren Buffett Warns Investing At 'Too-High Purchase Price' Even for 'an Excellent Company' Can Undo a Decade of Smart Investing BitMine Immersion Now Holds 1.15 Million Ethereum Tokens. Should You Buy BMNR Stock Here? Why Archer Aviation's (ACHR) Post-Earnings Tailspin Looks Like a Favorably Mispriced Opportunity Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! Momentus stock has been in a sharp downtrend since the start of 2025. Even after today's surge, it's down more than 80% versus its year-to-date high set in early January. Significance of NASA Contract for Momentus Stock The contract Momentus announced with NASA this morning is significant for investors primarily because it validates its technology and strengthens its credibility in the commercial space sector. The award positions MNTS as a potential platform for deploying advanced robotics in orbit, which is a high-value niche with growing demand. Additionally, it suggests future revenue opportunities tied to government partnerships and in-space servicing. In short, an endorsement from NASA can catalyze investor confidence, attract institutional interest, and support long-term viability, all of which could lead to an increase in MNTS share price over time. Avoid Chasing the Rally in MNTS Shares While the NASA announcement sure is meaningfully positive for Momentus, investors should still practice caution in chasing this morning's rally since it is a penny stock. Penny stocks are often prone to manipulation and tend to reverse gains just as quickly as they are racked up, especially when the upside is not backed by strong financials. Moreover, Momentus shares do not currently receive coverage from Wall Street analysts, another letdown for serious investors given it reflects limited institutional interest and a lack of confidence in the company's long-term visibility and financial viability. In conclusion, MNTS stock remains a speculative name with fragile fundamentals and minimal analyst oversight. Therefore, investors view today's surge in the commercial space company as a sentiment-driven spike, not a sustainable turnaround, until clearer financial traction and institutional support emerge. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
4 hours ago
- Yahoo
Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the . On August 8, Leerink Partners analyst Mike Kratky reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT), keeping the associated price target at $83. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. He based the optimistic rating on the stability and growth of PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) performance, stating that the company reported a 4% sales beat in Q2. This growth was attributed to strong international momentum and higher average selling prices in the US. The analyst added that the company's full-year sales guidance was raised slightly despite a softer Q3, and the gross margin guidance was improved as well. This suggests a positive outlook for the rest of the year, according to the analyst. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a commercial-stage surgical robotics company that develops transformative solutions for urology. The company manufactures and sells the AquaBeam Robotic System, which is an image-guided, surgical robotic system used in minimally invasive urologic surgery. While we acknowledge the potential of PRCT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
5 hours ago
- Yahoo
Why Centrus Energy Stock Crashed Today
Key Points Centrus Energy announced a large debt issuance last night. The uranium supply company could raise as much as $750 million in new cash. It could also be setting up investors for a large amount of stock dilution. 10 stocks we like better than Centrus Energy › Shares of Centrus Energy (NYSEMKT: LEU) nosedived 9.9% through 9:45 a.m. ET Wednesday. The supplier of low-enriched uranium used as atomic fuel for nuclear power plants announced last night that it will issue $650 million worth of convertible senior notes due in 2032 (i.e., debt convertible into stock) in an effort to raise the cash it needs to build a supplemental business producing high-assay, low-enriched uranium (HALEU) for use in advanced reactors. Details, details If there's sufficient interest among the banks underwriting the debt offering, Centrus might upsize its debt offering by $100 million, to $750 million total. Centrus hasn't yet said what interest rate the notes will pay, although in deals like these notes often pay interest below market rates for ordinary debt. The downside for investors is more on the convertible side of things -- where the company issuing the notes eventually lets its lenders convert the notes into equity in the company, diluting the shareholdings of existing investors. Should you sell Centrus stock? It's not immediately clear why Centrus is doing this offering. Profitable where most "nuclear stocks" are losing money, Centrus generates significant free cash flow already -- $107 million over the last 12 months -- so there seems to be no immediate cash need. Indeed, Centrus already has more cash than debt on its balance sheet, and seems in a pretty healthy condition. Viewed most favorably, this suggests Centrus will probably get pretty good terms on its debt offering, keeping interest expense low. It also suggests Centrus has a deal in mind, or at the very least, is prepared to make a big push toward building out its HALEU uranium business. Investors are selling Centrus stock, and I understand why. But I rather suspect they should be buying Centrus stock instead. Should you buy stock in Centrus Energy right now? Before you buy stock in Centrus Energy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Centrus Energy wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Centrus Energy Stock Crashed Today was originally published by The Motley Fool